Show simple item record

dc.contributor.authorKent, Lisa
dc.contributor.authorO'Neill, Brenda
dc.contributor.authorDavison, Gareth
dc.contributor.authorNevill, Alan M.
dc.contributor.authorMurray, Joyce
dc.contributor.authorReid, Alastair
dc.contributor.authorElborn, J Stuart
dc.contributor.authorBradley, Judy M
dc.date.accessioned2013-08-12T16:08:40Z
dc.date.available2013-08-12T16:08:40Z
dc.date.issued2012-12
dc.identifier.citationCycle ergometer tests in children with cystic fibrosis: reliability and feasibility. 2012, 47 (12):1226-34 Pediatr. Pulmonol.en_GB
dc.identifier.issn1099-0496
dc.identifier.pmid22615178
dc.identifier.doi10.1002/ppul.22578
dc.identifier.urihttp://hdl.handle.net/2436/297951
dc.description.abstractThe aim of this study was to assess the reliability and feasibility of cycle ergometer tests in young children with cystic fibrosis (CF). Children with CF aged 6-11 years and with stable lung disease performed two cycle ergometry tests (intermittent sprint and continuous incremental) on two occasions 1 week apart. Reliability was assessed using repeated-measures ANOVA. Bias was considered to be significant at P < 0.05 level and a coefficient of variation (CV) below 10% was considered acceptable. Feasibility and acceptability data were also collected. Sixteen children with CF completed the study: (9M:7F), 8.7(1.8) years, FEV(1) %predicted: 88.1(17.4). Power measurements recorded during the intermittent sprint test demonstrated significant bias over days (P < 0.05) and CVs were between 10% and 15%. Peak work capacity recorded during the continuous incremental test was reliable (bias P < 0.05, CV < 10%), as was heart rate and SpO(2) recorded during both tests (bias P < 0.05, CV < 10%). No problems were experienced in administering the tests and all children completed both tests on two separate occasions. There was a mixed response to questions on acceptability of tests. This is the first study to provide information on the reliability of performance measures recorded during an intermittent sprint protocol (peak power) and a continuous incremental cycle ergometry (peak work capacity) in children with CF.
dc.language.isoenen
dc.rightsArchived with thanks to Pediatric pulmonologyen_GB
dc.subject.meshAnalysis of Varianceen_GB
dc.subject.meshChilden_GB
dc.subject.meshCystic Fibrosisen_GB
dc.subject.meshExercise Testen_GB
dc.subject.meshFeasibility Studiesen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHumansen_GB
dc.subject.meshMaleen_GB
dc.subject.meshPatient Acceptance of Health Careen_GB
dc.subject.meshReproducibility of Resultsen_GB
dc.subject.meshSpirometryen_GB
dc.titleCycle ergometer tests in children with cystic fibrosis: reliability and feasibility.en
dc.typeJournal article
dc.identifier.journalPediatric pulmonologyen_GB
html.description.abstractThe aim of this study was to assess the reliability and feasibility of cycle ergometer tests in young children with cystic fibrosis (CF). Children with CF aged 6-11 years and with stable lung disease performed two cycle ergometry tests (intermittent sprint and continuous incremental) on two occasions 1 week apart. Reliability was assessed using repeated-measures ANOVA. Bias was considered to be significant at P < 0.05 level and a coefficient of variation (CV) below 10% was considered acceptable. Feasibility and acceptability data were also collected. Sixteen children with CF completed the study: (9M:7F), 8.7(1.8) years, FEV(1) %predicted: 88.1(17.4). Power measurements recorded during the intermittent sprint test demonstrated significant bias over days (P < 0.05) and CVs were between 10% and 15%. Peak work capacity recorded during the continuous incremental test was reliable (bias P < 0.05, CV < 10%), as was heart rate and SpO(2) recorded during both tests (bias P < 0.05, CV < 10%). No problems were experienced in administering the tests and all children completed both tests on two separate occasions. There was a mixed response to questions on acceptability of tests. This is the first study to provide information on the reliability of performance measures recorded during an intermittent sprint protocol (peak power) and a continuous incremental cycle ergometry (peak work capacity) in children with CF.


This item appears in the following Collection(s)

Show simple item record